-
1دورية أكاديمية
المؤلفون: Filipa Lynce, Laura E. Stevens, Zheqi Li, Jane E. Brock, Anushree Gulvady, Ying Huang, Faina Nakhlis, Ashka Patel, Jeremy M. Force, Tufia C. Haddad, Naoto Ueno, Vered Stearns, Antonio C. Wolff, Amy S. Clark, Jennifer R. Bellon, Edward T. Richardson, Justin M. Balko, Ian E. Krop, Eric P. Winer, Paulina Lange, E. Shelley Hwang, Tari A. King, Sara M. Tolaney, Alastair Thompson, Gaorav P. Gupta, Elizabeth A. Mittendorf, Meredith M. Regan, Beth Overmoyer, Kornelia Polyak
المصدر: Breast Cancer Research, Vol 26, Iss 1, Pp 1-14 (2024)
مصطلحات موضوعية: Inflammatory breast cancer, Triple negative, Ruxolitinib, Paclitaxel, Neoadjuvant, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1465-542XTest
-
2دورية أكاديمية
المؤلفون: Aditi Hazra, Andrea O’Hara, Kornelia Polyak, Faina Nakhlis, Beth T. Harrison, Antonio Giordano, Beth Overmoyer, Filipa Lynce
المصدر: Cells, Vol 12, Iss 7, p 1086 (2023)
مصطلحات موضوعية: inflammatory breast cancer, copy number variation, copy number alterations, multi-omics, subtype, triple-negative, Cytology, QH573-671
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Filipa Lynce, Laura E. Stevens, Zheqi Li, Jane E. Brock, Anushree Gulvady, Ying Huang, Faina Nakhlis, Ashka Patel, Jeremy M. Force, Tufia C. Haddad, Naoto Ueno, Vered Stearns, Antonio C. Wolff, Amy S. Clark, Jennifer R. Bellon, Edward T. Richardson, Justin M. Balko, Ian E. Krop, Eric P. Winer, Paulina Lange, E. Shelley Hwang, Tari A. King, Sara M. Tolaney, Alastair Thompson, Gaorav P. Gupta, Elizabeth A. Mittendorf, Meredith M. Regan, Beth Overmoyer, Kornelia Polyak
مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Pharmacology, Immunology, Cancer, Infectious Diseases, Virology, Space Science, Inflammatory breast cancer, Triple negative, Ruxolitinib, Paclitaxel, Neoadjuvant
الإتاحة: https://doi.org/10.6084/m9.figshare.25123842.v1Test
https://figshare.com/articles/journal_contribution/Additional_file_1_of_TBCRC_039_a_phase_II_study_of_preoperative_ruxolitinib_with_or_without_paclitaxel_for_triple-negative_inflammatory_breast_cancer/25123842Test -
4تقرير
المؤلفون: Eisai Inc.
المساهمون: Filipa Lynce, MD, Principal Investigator
المصدر: A Phase 2 Study of Eribulin Followed by Doxorubicin and Cyclophosphamide as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02623972Test